CRWV Earnings

CRWV reported its earnings on 2025-11-10, showcasing a revenue of 1.00B against an estimate of 1.00B, resulting in a 6.32% surprise. The EPS was -0.22, surpassing the expected -0.39 by 43.59% . The stock experienced a -16.31% price change on the earnings day and a -26.75% change over the next five days, reflecting market reactions to the results.

Following CRWV's earnings announcement on 2025-11-10, the stock price moved by -16.31% on the day of the release. Over the subsequent five days, it saw a -26.75% change. Historically, CRWV's stock price tends to shift by an average of -12.28% in the 10 days leading up to earnings and -4.14% in the 10 days following, providing insight into potential market.

For , analysts estimate CRWV’s annual revenue to reach , while the EPS is projected at . These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Downward by -2.93% and EPS estimates Revise Downward by -14.44% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between CRWV's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Downward by -2.93%, while EPS estimates moved Revise Downward by -14.44% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, CRWV's stock price typically moves by -12.28% in the 10 days before its earnings and -4.14% in the 10 days after. For the upcoming earnings, analysts expect an EPS of and revenue of .

The earnings call summary presents a mixed picture. Basic financial performance shows strong revenue guidance, but increased interest expenses and CapEx could raise concerns. Product development is positive with fungible infrastructure and strong market strategy. However, Q&A reveals systemic delays and vague responses from management, creating uncertainty. Shareholder return plans are not mentioned. Despite some optimistic guidance, risks from supply chain issues and lack of clear solutions temper enthusiasm, resulting in a neutral sentiment.